Sign inJoin waitlistJoin the waitlist

Seema Khan

Professor, Surgery · McGaw Medical Center of Northwestern University

Credentials: · · · ·

History

McGaw Medical Center of Northwestern University
Present
McGaw Medical Center of Northwestern University
Present

University of Rochester Medicine
1984–1986
SUNY Upstate Medical University
1982–1984
Surgery
St Agnes HealthCare
1978–1982
Dow University of Health Sciences
1974–1978

Research

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 914 citations
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Journal of Clinical Oncology · 2021 · 841 citations
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Journal of the National Comprehensive Cancer Network · 2017 · 377 citations

Nora Hansen
28 papers
Kevin Bethke
23 papers
SC
Susan Clare
22 papers
MM
Monica Morrow
15 papers
William Gradishar
15 papers
John Y Kim
13 papers
Joseph Sparano
10 papers
Neil Fine
10 papers
SK
Swati Kulkarni
10 papers
Jacqueline Jeruss
9 papers
Megan Sullivan
9 papers · 1 as a fellow
Ritu Nayar
9 papers

Grants

Northwestern Cancer Prevention Consortium
National Cancer Institute · UG1
Contact PI · $11.9M · Northwestern University
2019–2031
The Robert H. Lurie Comprehensive Cancer Center
National Cancer Institute · P30
Project lead · $566.8K · Northwestern University
1997–2030
COllaborative Northwestern Surgical Oncology Research Training (CONSORT)
National Cancer Institute · T32
Contact PI · $1.4M · Northwestern University
2020–2026
Determinants of Transdermal Drug Delivery to the Normal and the Radiated Breast
National Cancer Institute · R01
Contact PI · $2M · Northwestern University
2019–2026

Clinical trials

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2028
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
Principal investigator · Active not recruiting · Phase 2
Northwestern University
2020–2026
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
2018–2027
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
Principal investigator · Completed · Phase 2
Northwestern University
2017–2022